Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent

You'll face questions about whether it's okay for patients to switch antiplatelets after a coronary stent.

Current guidelines prefer dual antiplatelet therapy with aspirin plus ticagrelor (Brilinta) or prasugrel (Effient, etc) after an acute coronary syndrome (ACS)...instead of aspirin plus clopidogrel (Plavix, etc).

Earlier studies suggest that ticagrelor or prasugrel reduces the risk of a recurrent CV event more than clopidogrel.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals